Business Description
![Altimmune Inc Altimmune Inc logo](https://static.gurufocus.com/logos/0C00000B8L.png?14)
Altimmune Inc
NAICS : 325412
SIC : 2834
ISIN : US02155H1014
Compare
Compare
Traded in other countries / regions
ALT.USA0A4C.UK3G0.GermanyALT1.Mexico IPO Date
2017-02-21Description
Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 329.75 | |||||
Equity-to-Asset | 0.92 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 15.71 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -70.7 | |||||
3-Year EBITDA Growth Rate | 7.8 | |||||
3-Year EPS without NRI Growth Rate | 9.3 | |||||
3-Year FCF Growth Rate | -1.8 | |||||
3-Year Book Growth Rate | -23.3 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 66.21 | |||||
9-Day RSI | 59.12 | |||||
14-Day RSI | 54.58 | |||||
6-1 Month Momentum % | -38.09 | |||||
12-1 Month Momentum % | 109.62 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 16.55 | |||||
Quick Ratio | 16.55 | |||||
Cash Ratio | 16.06 | |||||
Days Sales Outstanding | 477.53 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -23.9 | |||||
Shareholder Yield % | -16.92 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -21596.34 | |||||
Net Margin % | -22626.1 | |||||
FCF Margin % | -17523.96 | |||||
ROE % | -54.38 | |||||
ROA % | -49.56 | |||||
ROIC % | -963.24 | |||||
ROC (Joel Greenblatt) % | -12046.38 | |||||
ROCE % | -53.04 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 900 | |||||
PB Ratio | 2.95 | |||||
Price-to-Tangible-Book | 2.95 | |||||
EV-to-EBIT | -3.55 | |||||
EV-to-EBITDA | -3.63 | |||||
EV-to-Forward-EBITDA | -3.74 | |||||
EV-to-Revenue | 802.5 | |||||
EV-to-Forward-Revenue | 11.45 | |||||
EV-to-FCF | -4.52 | |||||
Price-to-Net-Current-Asset-Value | 2.96 | |||||
Price-to-Net-Cash | 3.07 | |||||
Earnings Yield (Greenblatt) % | -28.17 | |||||
FCF Yield % | -14.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Altimmune Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.384 | ||
EPS (TTM) (€) | -1.487 | ||
Beta | 1.27 | ||
Volatility % | 285.15 | ||
14-Day RSI | 54.58 | ||
14-Day ATR (€) | 0.431612 | ||
20-Day SMA (€) | 6.06545 | ||
12-1 Month Momentum % | 109.62 | ||
52-Week Range (€) | 1.97 - 13.695 | ||
Shares Outstanding (Mil) | 70.9 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Altimmune Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Altimmune Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Altimmune Inc Frequently Asked Questions
What is Altimmune Inc(STU:3G0)'s stock price today?
The current price of STU:3G0 is €6.63. The 52 week high of STU:3G0 is €13.70 and 52 week low is €1.97.
When is next earnings date of Altimmune Inc(STU:3G0)?
The next earnings date of Altimmune Inc(STU:3G0) is 2024-08-09 Est..
Does Altimmune Inc(STU:3G0) pay dividends? If so, how much?
Altimmune Inc(STU:3G0) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |